Longitudinal oral and gut microbiota profiling in AML patients undergoing intensive chemotherapy
We profiled the microbiota in longitudinal salivary, supragingival plaque, and fecal samples from patients undergoing intensive chemotherapy at Fred Hutch Cancer Center, Seattle, WA. Samples were collected at baseline, week 2, week 3, and week 4 of chemotherapy. Shotgun metagenomes and clinical data were analyzed.